Boston Scientific Corp (BSX)vsPerspective Therapeutics Inc. (CATX)
BSX
Boston Scientific Corp
$44.23
-2.06%
HEALTHCARE · Cap: $60.84B
CATX
Perspective Therapeutics Inc.
$0.84
+2.08%
HEALTHCARE · Cap: $131.27M
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 5151489% more annual revenue ($21.07B vs $409,000). BSX leads profitability with a 16.6% profit margin vs 0.0%. BSX earns a higher WallStSmart Score of 62/100 (C+).
BSX
Buy62
out of 100
Grade: C+
CATX
Avoid29
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-9.2%
Fair Value
$39.15
Current Price
$44.23
$5.08 premium
Intrinsic value data unavailable for CATX.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Growing faster than its price suggests
Attractively priced relative to earnings
Reasonable price relative to book value
Strong operational efficiency at 20.2%
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
1.4% revenue growth
Distress zone — elevated risk
Earnings declined 21.5%
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on Market Cap, PEG Ratio, P/E Ratio. Profitability is solid with margins at 16.6% and operating margin at 20.2%. PEG of 0.63 suggests the stock is reasonably priced for its growth.
Bull Case : CATX
The strongest argument for CATX centers on Price/Book, Debt/Equity.
Bear Case : BSX
The primary concerns for BSX are Revenue Growth, Altman Z-Score, EPS Growth.
Bear Case : CATX
The primary concerns for CATX are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
CATX carries more volatility with a beta of 1.85 — expect wider price swings.
BSX is growing revenue faster at 1.4% — sustainability is the question.
BSX generates stronger free cash flow (868M), providing more financial flexibility.
Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BSX scores higher overall (62/100 vs 29/100), backed by strong 16.6% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Perspective Therapeutics Inc.
HEALTHCARE · MEDICAL DEVICES · USA
Perspective Therapeutics Inc. (CATX) is a pioneering biotechnology firm focused on revolutionizing cancer care through the development of innovative radiopharmaceuticals. Leveraging state-of-the-art radioisotope technologies, CATX seeks to enhance the precision and effectiveness of cancer therapies, aiming to significantly improve patient survival rates across various malignancies. Backed by a seasoned leadership team and strong strategic alliances, the company is strategically positioned to drive advancements in targeted cancer treatments, addressing significant healthcare challenges in a competitive landscape.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?